Homeowner Energy Freedom Act This bill repeals the Department of Energy's (1) high-efficiency electric home rebate program for certain electrification projects in low- or moderate-income households, (2) state-based home energy efficiency contractor training grants, and (3) assistance for states and local governments to adopt specified building energy codes. It also rescinds any unobligated balances available for the rebates or adopting the building energy codes. (The unobligated balances for the contractor training grants were previously rescinded by the 2025 reconciliation act.)
This bill amends the Consumer Product Safety Act to empower the Consumer Product Safety Commission to mandate recalls of consumer products made in China (including Hong Kong/Macao) without manufacturer consent if the product poses a substantial hazard. It directly affects Chinese manufacturers, retailers, and Chinese-owned e-commerce platforms (like Alibaba or JD.com) selling products to U.S. consumers. Key provisions require the Commission to issue recalls when: the product is from China, sold directly to U.S. consumers, the manufacturer failed to respond to safety requests, and a hazard is determined - creating a rebuttable presumption of hazard. The Commission must publish recall notices 30 days in advance on its website and notify distributors/platforms.
This bill amends a definition in existing law to clarify which countries are considered "foreign countries of concern" for restrictions on foreign talent recruitment in federally funded research. It directly affects research institutions and programs receiving federal funding under the Research and Development, Competition, and Innovation Act. The key change broadens the definition to include any program, position, or activity (whether directly or indirectly provided) involving foreign talent recruitment, removing prior limitations on how such recruitment might occur. This adjustment ensures the restriction applies more comprehensively to prevent malign foreign influence in U.S. research.
HR 5704 would repeal the Smith-Mundt Modernization Act of 2013, restoring the original 1948 law that prohibits U.S. government agencies like the State Department and U.S. Agency for Global Media (USAGM) from sharing materials intended for foreign audiences within the United States. The bill requires such materials to be made available in English for review by the press and Congress but blocks domestic distribution, mandates they be archived by the National Archives for 20 years before public access with clear disclaimers about their origin, and bans using federal funds to influence domestic public opinion. This would directly affect how these agencies produce and handle international communications.
This bill prohibits U.S. federal agencies from issuing vaccine verification documents (like "passports") or sharing citizens' COVID-19 vaccination records with third parties. It also bans requiring proof of vaccination for access to federal property, services, or congressional areas. The law directly affects how federal agencies handle health data and access to government facilities during the pandemic.
HR 1919, the "Anti-CBDC Surveillance State Act," prohibits the Federal Reserve from developing, testing, or issuing any central bank digital currency (CBDC) or similar digital assets. It specifically bans the Fed from offering direct financial products to individuals, maintaining individual accounts, or issuing CBDCs directly or indirectly through intermediaries like banks. The bill also blocks the Fed from using any digital asset for monetary policy and clarifies that physical currency's privacy protections remain intact. This policy directly affects the Federal Reserve System's ability to create or manage digital monetary tools.
HR 1122, the China Technology Transfer Control Act of 2025, requires the U.S. President to control exports of specific technologies and intellectual property to China after 180 days of enactment. It targets "covered national interest technology" defined as items aiding China's military, supporting its Made in China 2025 industrial policy (like semiconductors or AI), or used in human rights violations. The bill mandates sanctions against foreign entities that knowingly transfer such technology to China, with exceptions for imported goods. It also directs the U.S. Trade Representative to create an annual list of China-produced goods tied to these policies or human rights abuses.
HR 1430, the "No CBDC Act," prohibits federal entities like the Federal Reserve, Treasury Department, and their agents from creating, issuing, or managing central bank digital currency (CBDC) for individuals or businesses. The bill specifically bans these agencies from minting CBDC directly to people, offering CBDC-related services, maintaining individual accounts (including through intermediaries), or holding government-issued digital currency on their balance sheets. It directly affects the Federal Reserve and other federal agencies by blocking their role in developing a government-run digital currency system. The law aims to prevent federal involvement in digital currency issuance, focusing on restricting specific actions by government bodies rather than impacting private digital currency markets.
HR 4894, the Deceptive Practices and Voter Intimidation Prevention Act of 2025, prohibits the intentional spread of false information about voting procedures, eligibility, or penalties within 60 days of an election. The bill specifically targets deceptive communications through social media, text messages, and AI-generated content designed to prevent voters from casting ballots, including false claims about voting locations, registration status, or legal consequences. It creates a private right of action for individuals harmed by these deceptive practices and authorizes the Attorney General to issue corrective information to counter false claims. The law directly affects voters, election officials, social media platforms, and anyone spreading false voting information, with penalties including fines and imprisonment for violations.
H.J.Res. 74 disapproves a rule by the Bureau of Consumer Financial Protection (BCFP) that would have prohibited creditors and consumer reporting agencies from using medical information - such as unpaid medical bills - in credit reports and credit scoring. The rule, published in the Federal Register on January 14, 2025, aimed to prevent medical debt from affecting credit scores. If enacted, this resolution would block the rule from taking effect, maintaining the current practice where medical debt can influence credit decisions. This disapproval follows standard Congressional Review Act procedures for overturning agency rules.
